Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

396.22
Delayed Data
As of May 27
 +2.68 / +0.68%
Today’s Change
348.96
Today|||52-Week Range
605.93
-27.01%
Year-to-Date
Better Buy: Regeneron Pharmaceuticals, Inc. vs. Roche
May 27 / MotleyFool.com - Paid Partner Content
Baron Funds Comments on Regeneron Pharmaceuticals
May 23 / GuruFocus News - Paid Partner Content
Frank Sands Sells Visa, Baidu, Alibaba
May 24 / GuruFocus News - Paid Partner Content
Better Buy: Regeneron Pharmaceuticals, Inc. vs. Ophthotech
May 17 / MotleyFool.com - Paid Partner Content
Pfizer's Buyout of Anacor Pharmaceuticals for $5.2 Billion Is a Bad Move -- Here's Wh...
May 24 / MotleyFool.com - Paid Partner Content
3 Stocks You Can Buy and Hold Forever
May 16 / MotleyFool.com - Paid Partner Content
How I Made a Huge Profit on Regeneron -- And It was One of My Biggest Mistakes Ever
May 24 / TheStreet.com - Paid Partner Content
Biotech groups sink their teeth into the Big Apple
May 16 / FT.com - Paid Partner Content

Today’s Trading

Previous close393.54
Today’s open398.49
Day’s range389.62 - 398.49
Volume548,059
Average volume (3 months)988,245
Market cap$41.6B
Dividend yield--
Data as of 4:00pm ET, 05/27/2016

Growth & Valuation

Earnings growth (last year)+79.80%
Earnings growth (this year)-6.46%
Earnings growth (next 5 years)+17.70%
Revenue growth (last year)+45.55%
P/E ratio62.9
Price/Sales15.24
Price/Book11.34

Competitors

 Today’s
change
Today’s
% change
QQuintiles Transnatio...-0.04-0.06%
ALNYAlnylam Pharmaceutic...-3.00-4.25%
CRLCharles River Labora...+0.52+0.61%
ICLRICON PLC+0.43+0.63%
Data as of 4:04pm ET, 05/27/2016

Financials

Next reporting dateAugust 2, 2016
EPS forecast (this quarter)$2.69
Annual revenue (last year)$4.1B
Annual profit (last year)$636.1M
Net profit margin15.50%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Leonard S. Schleifer
Chief Financial Officer &
Senior VP-Finance
Robert E. Landry
Corporate headquarters
Tarrytown, New York

Forecasts

Partner Offers

Search for Jobs